The anti-melanoma differentiation-associated gene antibody (anti-MDA5) is a myositis-specific autoantibody (MSA) against a 140-kDa polypeptide described by Sato et al. in 8 Japanese patients with clinically amyopathic dermatomyositis (CADM) [2]. The gene discussed is IFIH1; the disease is myositis disease.